SAN ANTONIO--(BUSINESS WIRE)--Feb 26, 2019--Rapamycin Holdings, ... The rebrand to Emtora Biosciences enables a dynamic and meaningful ...
News
- Rapamycin Holdings, Inc. Rebrands to Emtora Biosciences as New Leadership Focuses Company ...
- Eni (E) Initiates Construction of 31MW Photovoltaic Plant
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They're also finding ...
- Another San Antonio biotech changing its name and CEO
San Antonio-based Rapamycin Holdings Inc. has changed its top executive, as well as its name. Carole Spangler Vaughn has been named CEO of ...
- Texas Makes Move to Lure Companies to the State to Enhance Its Biotech Industry
That life sciences center in San Antonio isn't the only recruitment being undertaken in Texas. Robert Allen, president and chief executive officer of the ...
- San Antonio, Darmstadt Leaders on How to Be a 'City of the Future'
San Antonio, Darmstadt Leaders on How to Be a 'City of the Future' ... The German city of Darmstadt, San Antonio's “sister city,” has been named by ... biomedical, cybersecurity, and technological institutions and companies.